SCHEMBL25913446

SCHEMBL25913446

Cn1cccc(-c2ccc3cc(Oc4ccnc(Br)c4)ccc3n2)c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 3/20 0.35
▸ MAOB P27338 3/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ NOD2 Q9HC29 1/20 0.34
▸ SCN7A Q01118 2/20 0.33
▸ KCNH2 Q12809 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ BRAF P15056 7/20 0.33
▸ SCN5A Q14524 1/20 0.32
▸ SCN2A Q99250 1/20 0.32
▸ SCN8A Q9UQD0 1/20 0.32
▸ RAF1 P04049 2/20 0.32
▸ GRM2 Q14416 1/20 0.31
▸ KDM4C Q9H3R0 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25913433 0.82 BRAF (0.46) BRAF
SCHEMBL25913399 0.80 CSF1R (0.39) MAOBMEN1ALDH1A1HTTKMT2A
SCHEMBL25914740 0.78 CSF1R (0.35) MEN1ALDH1A1HTTKMT2ANOD2
SCHEMBL25911790 0.77 CSF1R (0.53) BRAFRAF1
SCHEMBL25914665 0.74 CSF1R (0.39) MAOBBRAFRAF1
SCHEMBL25913444 0.74 ESR1 (0.48) MAOAMAOBMEN1ALDH1A1KMT2A
SCHEMBL25912706 0.73 CSF1R (0.43) MAOBBRAFRAF1
SCHEMBL25913040 0.72 KDM4E (0.38) ALDH1A1SCN7AKCNH2BRAF
SCHEMBL25914331 0.69 DYRK1A (0.35) MEN1ALDH1A1KMT2ABRAFHDAC8
SCHEMBL25316908 0.69 BRAF (0.32) SCN7AKCNH2BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback